FilingReader Intelligence
Torrent Pharma to acquire J.B. Chemicals, strengthen IPM presence
June 30, 2025 at 07:05 AM UTC•By FilingReader AI
Torrent Pharmaceuticals (BSE: TORNTPHARM) has announced a definitive agreement to acquire a controlling 46.39% stake in J.B. Chemicals & Pharmaceuticals from KKR for a cash consideration of INR 11,917 crore, or INR 1,600 per share, subject to shareholder and regulatory approvals. The acquisition will be followed by a merger between Torrent and J.B. Chemicals, further integrating their businesses.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:TORNTPHARM•Bombay Stock Exchange
News Alerts
Get instant email alerts when Torrent Pharmaceuticals publishes news
Free account required • Unsubscribe anytime